JCB logo
Cytokines in immune regulation
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online December 18, 2007
doi:10.1083/jcb.1797rr5
The Journal of Cell Biology, Vol. 179, No. 7, 1329-
The Rockefeller University Press, 0021-9525 $30.00
© 2007 Robinson
This Article
Right arrow PDF (Full Text)
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Robinson, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Robinson, R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Research Roundup

Lipid + Alzheimer's plaque = problem

Lipids rapidly dissolve Alzheimer's disease plaques into toxic protofibrils, according to Joost Schymkowitz, Frederic Rousseau (Vrije Universiteit Brussel, Belgium), and colleagues.

Insoluble amyloid plaques of the Aβ protein are found throughout the Alzheimer's brain but are thought to be largely inert. By contrast, oligomeric protofibrils—the intermediate between soluble Aβ and insoluble amyloid—are known to be neurotoxic. But once they make plaques, protofibrils were not thought to escape back into toxic form.

Because disturbed lipid metabolism has been implicated in Alzheimer's development, the authors tested the effects of lipids on plaque solubility. When subjected to a variety of naturally occurring lipids, plaques released large amounts of protofibrils that were toxic to neurons in culture. Injecting a mixture of lipids and amyloids into the mouse brain caused memory deficits not seen with either alone. "If the brain harbors a lot of aggregates, it can be a significant reservoir of toxic material," Rousseau says, which may contribute to worsening Alzheimer's disease.

As a silver lining, Rousseau notes, the discovery may make antiprotofibril antibody production much easier, because abundant quantities of protofibrils can be kept in solution for long periods. Formula

Reference:

Martins, I.C., et al. 2007. EMBO J. doi:10.1038/sj.emboj.7601953.



Richard Robinson

rrobinson{at}nasw.org


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow PDF (Full Text)
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Robinson, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Robinson, R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents